Licensing Issues Causes Public Skirmish with State Boards for Drug Companies The patchwork that is state licensure is a constant challenge for all companies in the pharmaceutical supply chain – from international drug manufacturers to independent distributors....
DSCSA to Cause Future State Regulation Changes State regulation of the pharmaceutical supply chain is a patchwork of different definitions, requirements, and enforcement– will this FDA proposed rule finally bring uniformity? Background The Drug Supply Chain Security...
Morphine Equivalency for Suspicious Order Monitoring Background In July 2016, at the height of the opioid epidemic, the West Virginia Attorney General’s Office and the West Virginia Board of Pharmacy came together to develop a calculator that converts opioid dosage...
Minnesota Board of Pharmacy Fee is a Barrier to Entry In 2019, Minnesota announced an increase in registration fees for wholesalers and manufacturers from $235 per year to $5,260 (read more information here). The 2,200% increase for Minnesota fees has created an...
PBMs Turn Up the Pressure on Diabetic Test Strip Reimbursements Two separate PBMs recently issued audits to an independent pharmacy because it was determined that the pharmacy was sourcing diverted test strips from an NABP DDA (fka VAWD®) Accredited facility. Against...
